| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.65 | 7e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |